首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Authors:Farmer Hannah  McCabe Nuala  Lord Christopher J  Tutt Andrew N J  Johnson Damian A  Richardson Tobias B  Santarosa Manuela  Dillon Krystyna J  Hickson Ian  Knights Charlotte  Martin Niall M B  Jackson Stephen P  Smith Graeme C M  Ashworth Alan
Institution:Cancer Research UK Gene Function and Regulation Group, London, UK.
Abstract:BRCA1 and BRCA2 are important for DNA double-strand break repair by homologous recombination, and mutations in these genes predispose to breast and other cancers. Poly(ADP-ribose) polymerase (PARP) is an enzyme involved in base excision repair, a key pathway in the repair of DNA single-strand breaks. We show here that BRCA1 or BRCA2 dysfunction unexpectedly and profoundly sensitizes cells to the inhibition of PARP enzymatic activity, resulting in chromosomal instability, cell cycle arrest and subsequent apoptosis. This seems to be because the inhibition of PARP leads to the persistence of DNA lesions normally repaired by homologous recombination. These results illustrate how different pathways cooperate to repair damage, and suggest that the targeted inhibition of particular DNA repair pathways may allow the design of specific and less toxic therapies for cancer.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号